ArticleEndocrine2021

Temozolomide alone or in combination with capecitabine in patients with advanced neuroendocrine neoplasms: an Italian multicenter real-world analysis.

Francesca Spada et al.PubMed ↗Publisher ↗

No numbers read from the abstract.